Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma()

Autor Geoerger, Birgit, Kieran, Mark W., Grupp, Stephan, Perek, Danuta, Clancy, Jill, Krygowski, Mizue, Ananthakrishnan, Revathi, Boni, Joseph P., Berkenblit, Anna, Spunt, Sheri L.
Vydáno 2011

Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors

Autor Spunt, Sheri L., Grupp, Stephan A., Vik, Terry A., Santana, Victor M., Greenblatt, David J., Clancy, Jill, Berkenblit, Anna, Krygowski, Mizue, Ananthakrishnan, Revathi, Boni, Joseph P., Gilbertson, Richard J.
Vydáno 2011

Lorlatinib in ALK- or ROS1-rearranged non-small cell lung cancer: an international, multicenter, open-label phase 1 trial

Autor Shaw, Alice T., Felip, Enriqueta, Bauer, Todd M., Besse, Benjamin, Navarro, Alejandro, Postel-Vinay, Sophie, Gainor, Justin F., Johnson, Melissa, Dietrich, Jorg, James, Leonard P., Clancy, Jill S., Chen, Joseph, Martini, Jean-François, Abbattista, Antonello, Solomon, Benjamin J.
Vydáno v Lancet Oncol (2017)

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

Autor Shaw, Alice T., Solomon, Benjamin J., Besse, Benjamin, Bauer, Todd M., Lin, Chia-Chi, Soo, Ross A., Riely, Gregory J., Ou, Sai-Hong Ignatius, Clancy, Jill S., Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D. Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M., Felip, Enriqueta, Martini, Jean-François
Vydáno v J Clin Oncol (2019)